Govt announces Rs 10-crore prize for new drug to treat sickle cell disease
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
The government on Thursday announced an award of Rs 10 crore to develop a drug for the treatment of sickle cell disease , which disproportionately affects India's tribal populations. Sickle cell disease is a group of inherited blood disorders that affect haemoglobin , causing red blood cells to become sickle-shaped and block the blood flow, which can lead to serious complications such as stroke, eye problems and infections.Prime Minister Narendra Modi launched the National Sickle Cell Anaemia Eradication Mission on July 1, 2023, with the aim of eradicating the disease by 2047. The government aims to screen seven crore people up to 40 years of age as part of the mission.At an event to mark World Sickle Cell Day here, Union Minister of State for Tribal Affairs Durgadas Uikey announced the institution of the Bhagwan Birsa Munda Prize for the development of a drug to treat the disease.The minister said there is only one drug available as of now for the management of the disease. There is currently no option to select a drug from a range of alternatives based on the patient's body conditions and severity of the disease.He said this problem is worsened in special situations like pregnancy or the presence of other serious medical conditions. Therefore, there is an urgent need to develop a new drug.The tribal affairs ministry, in collaboration with the AIIMS-Delhi, will undertake a competition for the development of the drug. The selected proposal will be funded up to Rs 10 crore, Uikey said.He also said the ministry will establish a Centre for Tribal Health and Research Institute under the AIIMS-Delhi.This centre will also have outpatient and inpatient facilities for providing the highest-quality medical care to tribal people. Provisions for seamless referrals from peripheral hospitals in tribal-dominated areas will be explored, he said.The centre will also guide the government in policy formulation.The minister said a postgraduate course in tribal medicine will also be designed.This will help address the long-standing health inequities faced by tribal communities, who often remain underserved due to geographical, socio-cultural and systemic barriers, he said.This specialised course will be designed to develop a cadre of medical professionals with contextual knowledge, clinical skills and public health competencies tailored to tribal settings.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
an hour ago
- Economic Times
They save lives, but who saves them? Surgeons face silent injuries in operation theatres; AIIMS and IIT-Delhi step in
Indian surgeons face health risks during long laparoscopic surgeries. IIT Delhi and AIIMS are collaborating to address this. They are designing new laparoscopic tools. The goal is to reduce strain and prevent long-term injuries. Prototypes for graspers, scissors, and needle holders are under development. Simulations are planned for January. Tired of too many ads? Remove Ads Why are surgeons in pain? What's the solution? Tired of too many ads? Remove Ads Why it matters Surgeons may be saving lives every day, but they're often putting their own health at risk in the process, especially during long laparoscopic surgeries. These operations, which require working with long, rigid tools while watching a screen, force doctors into stressful positions for hours. Shoulders stay hunched, wrists twist, and necks strain, all of which can lead to pain, fatigue, and serious long-term tackle this growing problem, IIT Delhi and AIIMS have teamed up to create a new generation of laparoscopic instruments with better design and ergonomics, reported robotic or open surgery, laparoscopic procedures limit how much a surgeon can move. 'We are working with 300mm-long tools, performing complex surgeries without the feel of touch,' explained Dr Sachit Anand, a paediatric surgeon at AIIMS. 'The stress on our muscles and joints is huge, but it's rarely discussed.'Prof Sabyasachi Paldas from IIT Delhi added that the design of existing tools causes repetitive hand movements and awkward body positions. This often results in musculoskeletal disorders that can affect a surgeon's ability to work in the long term.A joint team of surgeons and designers, including students like Nabeeha Akhtar from IIT Delhi, is using a detailed, multi-stage process to develop better tools. They are working on prototypes for graspers, scissors, and needle holders that aim to reduce stress on the body. The goal is to have working models ready by December, with simulations planned for January.'We're focusing on reducing fatigue and pain by improving posture and movement,' said Dr Gourab Kar from the IIT design department. He added that they're also looking at changes in the operating room itself, like adjusting the table height and monitor position.'In laparoscopy, you work in 2D but aim for 3D outcomes. Every move outside the body needs to be precise inside,' said Dr Anand. 'This puts extra pressure on the surgeon's wrists, fingers, spine and shoulders. It's even harder in Indian hospitals where we see high patient numbers and low awareness about ergonomics.'This initiative comes as India marks World Hepatitis Day with a focus on safer healthcare. It serves as a timely reminder that safety in healthcare should also include the well-being of doctors. After all, a healthy surgeon is essential for healthy from TOI
Business Standard
4 hours ago
- Business Standard
Sagility India gains after Q1 PAT soars 566% YoY to Rs 149 cr
Sagility India advanced 6.91% to Rs 45.34 after the company's consolidated net profit surged 566.49% to Rs 148.56 crore on a 25.8% jump in revenue from operations to Rs 1,538.94 crore in Q1 FY26 over Q1 FY25. Profit before tax (PBT) stood at Rs 210.39 crore in Q1 FY26, registering a surge of 196.3% compared to Rs 71.01 crore in Q1 FY25. In Q1 FY26, adjusted EBITDA stood at Rs 368.7 crore, up 26.44%, compared with Rs 291.6 crore posted in the same quarter last year. Adjusted EBITDA margin stood at 24% in Q1 FY26 as against 23.8% in Q1 FY25. In dollar terms, the company reported revenue of $180.4 million, while adjusted PAT stood at $23.4 million in Q1 FY26. As of 31st March 2025, the company had 39,917 employees. Attrition improved to 27.6% in Q1 FY26 as against 27.3% in Q1 FY25. Ramesh Gopalan, managing director and group CEO, said, Weve entered FY26 with strong momentum and confidence in our position as a leading provider of solutions and services for U.S. healthcare payers and providers. Despite ongoing regulatory and policy shifts, our business continues to demonstrate resilience and sustained growth. We are deepening engagement with both long-standing and newer clients while maintaining robust profitability. The integration of BroadPath is progressing smoothly. As our clients contend with increasing cost pressures, we are partnering with them to bring our domain and solution capabilities, along with automation and AI, to improve efficiencies and deliver better business outcomes. Sarvabhouman Srinivasan, Group Chief Financial Officer, added, We have started FY26 with a healthy revenue momentum and disciplined execution driving balanced financial performance. Margins remain stable, supported by improved delivery efficiency, cost optimization, and early gains from BroadPath integration. Cash generation continues to be robust, enabling us to fund strategic priorities and maintain financial flexibility. Our financial strategy remains focused: investing where it matters, operating efficiently, and ensuring that every growth initiative contributes to long-term value. Sagility India provides healthcare-focused, technology-enabled solutions and services primarily to U.S.-based clients in the payer and provider segments.
Time of India
4 hours ago
- Time of India
Blinkit pilots 10-minute delivery for prescription medicines in Bengaluru
Academy Empower your mind, elevate your skills Eternal-owned quick commerce platform Blinkit has started delivery of prescription medicines in select localities in Bengaluru . This will be in addition to the over-the-counter (OTC) medicine already available on the is delivering antibiotics, eye and ear drops, antihistamines and diabetes monitoring devices and drugs under its newly launched drug delivery service. It is also offering dermatological, oral care and neuro care delivery times vary between 10–30 minutes depending on the pincodes. There is no clarity on where Blinkit will source the medicines from or the underlying supply chain for the has emailed queries on the development to Blinkit, but is yet to get a was the first to report the development.A Crisil report on the online pharmacy market estimated that epharmacies currently make up 3–5% of India's pharmaceutical retail market, compared to 22–25% in some developed countries. The analytics firm valued the overall retail pharmacy market in the neighbourhood of Rs 2.4 lakh crore, with the unorganised sector representing an 85% drug delivery apps have grown in recent months. PhonePe's Pincode introduced 10-minute medicine deliveries in Bengaluru, Pune, and Mumbai in April. Eternal 's rival, Swiggy , reportedly partnered with Pharmeasy last year for quick delivery of medicines. Larger epharmacy platforms, including Tata 1mg and Netmeds, are also vying for rapid private pharmacy chain Davaindia has started 60-minute deliveries in Pune. Zeelab Pharmacy, which raised $2.4 million from OTP Ventures earlier this year, has started 60-minute deliveries in this enthusiasm is beset by the prospect of tighter regulations. Currently, there are no specific rules that exclusively govern online pharmacies. To remedy this, the government is preparing a new law to replace the existing drug regulations, which are not clearly defined, ET reported on June is already running a 10-minute ambulance service in Gurugram, scaling the number of vehicles from 5 in January to 12. These ambulances have responded to 594 calls so far, half of which were critical emergencies, Eternal 's chief executive Deepinder Goyal said in a social media post on July 24. They were able to reach patients in 10 minutes 83% of the time, Goyal company is now building an in-house paramedic training programme to expand its emergency care online medicine pilot comes as Eternal leans more on Blinkit in the backdrop of sluggishness in the food delivery business. The quick commerce player became the leading vertical for its parent in the April-June quarter, surpassing the net order value of the more mature food delivery arm, Zomato, and driving the 70% jump in is moving to an inventory-led model from September 1, which is likely to drive margin expansion , according to analysts.
